Glenmede Trust CO Na Cytosorbents Corp Transaction History

Glenmede Trust CO Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$7.65 - $8.98 $17,051 - $20,016	-2,229 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $501 - $784	68 Added 3.15%	2,229 $17,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $15,235 - $27,315	2,161 New	2,161 $16,000
Q3 2018 Nov 15, 2018	SELL	$10.95 - $14.8 $94,848 - $128,197	-8,662 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$6.9 - $12.35 $59,767 - $106,975	8,662 New	8,662 $98,000
Q4 2017 Feb 15, 2018	SELL	$5.9 - $7.05 $112,147 - $134,006	-19,008 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.5 - $6.2 $85,536 - $117,849	19,008	19,008 $0

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.